AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 19 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,969,000 | -71.1% | 7,118,000 | -75.1% | 0.00% | -62.5% |
| Q2 2022 | $24,135,000 | -6.8% | 28,618,000 | -0.3% | 0.01% | 0.0% |
| Q1 2022 | $25,891,000 | +17.6% | 28,700,000 | +9.5% | 0.01% | +33.3% |
| Q4 2021 | $22,009,000 | -6.5% | 26,200,000 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $23,547,000 | -8.8% | 26,200,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $25,808,000 | -3.8% | 26,200,000 | +0.4% | 0.01% | -11.1% |
| Q1 2021 | $26,830,000 | +19.4% | 26,100,000 | +6.5% | 0.01% | +12.5% |
| Q4 2020 | $22,465,000 | +123.2% | 24,500,000 | +96.0% | 0.01% | +100.0% |
| Q3 2020 | $10,066,000 | – | 12,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 9,100,000 | $8,937,000 | 3.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 174,372,000 | $170,826,000 | 3.40% |
| PFM Health Sciences, LP | 48,150,000 | $47,381,000 | 1.71% |
| DeepCurrents Investment Group LLC | 17,738,000 | $17,424,000 | 0.67% |
| Weiss Asset Management LP | 17,595,000 | $17,263,000 | 0.42% |
| DAFNA Capital Management LLC | 1,500,000 | $1,476,000 | 0.40% |
| Westchester Capital Management, LLC | 3,853,000 | $3,792,000 | 0.11% |
| Calamos Advisors LLC | 15,438,000 | $15,147,000 | 0.07% |
| Verition Fund Management LLC | 10,316,000 | $5,081,076 | 0.06% |
| OAKTREE CAPITAL MANAGEMENT LP | 2,532,000 | $2,491,000 | 0.03% |